2.225
0.015 (0.68%)
0.015 (0.68%)
Upgrade to Real-Time
Regular Market
Low
1.32
High
3.77
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Marker Therapeutics Inc | MRKR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.015 | 0.68% | 2.225 | 13:39:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.23 | 2.16 | 2.299 | 2.21 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 2.22 | 2.23 | 0.01 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 908 | 265,181 | $ 2.20 | $ 583,881 | - | 1.32 - 3.77 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 13:39:00 | 100 | $ 2.225 | USD |
Period:
Draw Mode:
Marker Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 184.71M | 83.01M | 58.33M | $ 466.79k | $ - | -0.62 | -3.50 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 73.29k | 21.50% |
Marker Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRKR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.17 | 2.38 | 2.1582 | 2.28 | 368,551 | 0.055 | 2.53% |
| 1 Month | 3.14 | 3.20 | 2.1582 | 2.58 | 526,059 | -0.915 | -29.14% |
| 3 Months | 2.59 | 3.65 | 2.04 | 2.74 | 1,338,513 | -0.365 | -14.09% |
| 6 Months | 2.03 | 3.77 | 1.7699 | 2.50 | 2,451,989 | 0.195 | 9.61% |
| 1 Year | 1.99 | 3.77 | 1.32 | 2.41 | 1,365,860 | 0.235 | 11.81% |
| 3 Years | 10.01 | 10.25 | 1.32 | 3.12 | 737,873 | -7.79 | -77.77% |
| 5 Years | 10.01 | 10.25 | 1.32 | 3.12 | 737,873 | -7.79 | -77.77% |
Marker Therapeutics Description
| Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart. |
